Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Bionano Genomics, Inc. (BNGO)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Mar-31-23Dec-31-22Jun-30-22Mar-31-22Dec-31-21Sep-30-21Jun-30-21
   10-Q10-Q8-K10-Q10-Q10-K10-Q10-Q
Net income  -38.9-37.1-38.7-32.2-30.0-22.9-20.8-18.8
Depreciation and amortization  3.33.2 2.32.21.90.50.5
Stock-based compensation  3.93.9 5.85.14.82.81.8
Deferred taxes       -5.8  
Change in working capital   [+]-6.1-3.0 -4.8-10.59.6-2.31.9
Other operating activities  1.00.6 0.60.7-13.1-0.22.1
Cash from operations  -36.7-32.4 -28.3-32.5-25.6-20.0-12.4
   
Capital expenditures   [+]-0.5-0.4 -0.2-0.2-0.5-0.3-0.1
Purchases of short-term investments, net  30.016.9 31.732.2-41.6-185.3 
Other cash from investing  0.1  -0.2-0.1-50.5  
Cash from investing  29.616.5 31.232.0-92.5-185.60.1
   
Issuance of common stock, net  18.315.2   0.014.1 
Option exercises        0.20.1
Other cash from financing  -0.4-0.4 0.20.02.0-0.1-17.0
Cash from financing  17.914.9 0.20.02.013.8-17.2
   
Free cash flow  -37.2-32.8 -28.6-32.6-26.1-20.3-12.5
        Per share (diluted)  ($1.18)($0.11) ($1.00)($0.11)($0.09)($0.07)($0.04)
   
Cash paid for interest  0.10.1 0.10.11.40.00.2

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy